Descriptions

The autoinhibited protein was predicted that may have potential autoinhibitory elements via cis-regPred.

Autoinhibitory domains (AIDs)

Target domain

Relief mechanism

Assay

cis-regPred

Accessory elements

No accessory elements

Autoinhibited structure

Activated structure

2 structures for Q9T0G7

Entry ID Method Resolution Chain Position Source
4NJ5 X-ray 240 A A 134-650 PDB
AF-Q9T0G7-F1 Predicted AlphaFoldDB

80 variants for Q9T0G7

Variant ID(s) Position Change Description Diseaes Association Provenance
ENSVATH14170788 4 S>P No 1000Genomes
ENSVATH00498992 18 L>V No 1000Genomes
ENSVATH11640710 19 I>M No 1000Genomes
tmp_4_7826535_G_A 24 P>L No 1000Genomes
ENSVATH14170787 25 V>A No 1000Genomes
ENSVATH11640709 31 N>D No 1000Genomes
ENSVATH06646064 32 L>F No 1000Genomes
ENSVATH06646063 33 A>V No 1000Genomes
ENSVATH11640708 37 P>L No 1000Genomes
tmp_4_7826497_G_A 37 P>S No 1000Genomes
tmp_4_7826493_T_G 38 N>T No 1000Genomes
ENSVATH06646062 43 A>V No 1000Genomes
ENSVATH00498991 48 A>P No 1000Genomes
ENSVATH00498991 48 A>T No 1000Genomes
tmp_4_7826434_A_T 58 F>I No 1000Genomes
ENSVATH06646058 60 S>A No 1000Genomes
ENSVATH06646057 61 D>E No 1000Genomes
tmp_4_7826425_C_T 61 D>N No 1000Genomes
tmp_4_7826424_T_A 61 D>V No 1000Genomes
ENSVATH02815065 78 Q>H No 1000Genomes
ENSVATH14170786 79 R>H No 1000Genomes
ENSVATH14170785 80 H>R No 1000Genomes
ENSVATH06646054 82 D>E No 1000Genomes
tmp_4_7826339_T_A 89 L>F No 1000Genomes
tmp_4_7826337_G_T 90 T>N No 1000Genomes
ENSVATH00498990 100 P>L No 1000Genomes
tmp_4_7826295_G_A 104 P>L No 1000Genomes
ENSVATH06646052 104 P>S No 1000Genomes
tmp_4_7826289_G_A 106 P>L No 1000Genomes
ENSVATH06646051 110 S>C No 1000Genomes
ENSVATH00498989 112 S>P No 1000Genomes
ENSVATH11640707 119 Q>K No 1000Genomes
ENSVATH00498988 122 R>K No 1000Genomes
ENSVATH14170744 139 E>V No 1000Genomes
tmp_4_7826187_C_T 140 S>N No 1000Genomes
tmp_4_7826170_C_G 146 E>Q No 1000Genomes
tmp_4_7826114_C_T 164 M>I No 1000Genomes
tmp_4_7826112_T_C 165 E>G No 1000Genomes
ENSVATH06646049 172 V>F No 1000Genomes
tmp_4_7826038_T_A 190 M>L No 1000Genomes
tmp_4_7826010_C_A 199 R>L No 1000Genomes
tmp_4_7825946_A_C 220 F>L No 1000Genomes
ENSVATH02815064 220 F>V No 1000Genomes
ENSVATH02815063 221 E>D No 1000Genomes
ENSVATH02815062 231 P>S No 1000Genomes
ENSVATH02815061 233 S>A No 1000Genomes
tmp_4_7825861_T_G 249 I>L No 1000Genomes
ENSVATH11640706 269 I>V No 1000Genomes
tmp_4_7825765_C_G 281 G>R No 1000Genomes
tmp_4_7825753_C_T 285 E>K No 1000Genomes
ENSVATH06646047 312 L>F No 1000Genomes
tmp_4_7825576_C_T 344 G>S No 1000Genomes
ENSVATH06646046 363 V>L No 1000Genomes
ENSVATH06646044 367 A>G No 1000Genomes
tmp_4_7825485_G_T 374 P>Q No 1000Genomes
ENSVATH06646043 376 S>T No 1000Genomes
ENSVATH00498985 394 V>D No 1000Genomes
tmp_4_7825420_C_G 396 V>L No 1000Genomes
ENSVATH06646042 416 Q>R No 1000Genomes
ENSVATH11640644 418 S>L No 1000Genomes
tmp_4_7825342_C_G 422 G>R No 1000Genomes
ENSVATH11640643 432 S>R No 1000Genomes
ENSVATH06646041 439 G>V No 1000Genomes
ENSVATH00498979 475 A>P No 1000Genomes
tmp_4_7825152_C_A 485 R>L No 1000Genomes
ENSVATH11640642 494 R>G No 1000Genomes
ENSVATH06646040 513 L>F No 1000Genomes
tmp_4_7825039_C_T 523 A>T No 1000Genomes
ENSVATH14170740 527 L>S No 1000Genomes
ENSVATH14170741 527 L>V No 1000Genomes
ENSVATH14170738 576 P>L No 1000Genomes
ENSVATH11640640 576 P>S No 1000Genomes
tmp_4_7824852_T_C 585 K>R No 1000Genomes
tmp_4_7824801_A_C 602 I>S No 1000Genomes
ENSVATH06646038 606 V>I No 1000Genomes
tmp_4_7824770_A_T 612 S>R No 1000Genomes
ENSVATH06646037 613 L>F No 1000Genomes
tmp_4_7824717_G_A 630 T>I No 1000Genomes
ENSVATH06646033 640 D>G No 1000Genomes
tmp_4_7824672_T_G 645 K>T No 1000Genomes

No associated diseases with Q9T0G7

3 regional properties for Q9T0G7

Type Name Position InterPro Accession
domain SET domain 493 - 643 IPR001214
domain SRA-YDG 200 - 356 IPR003105
domain Pre-SET domain 384 - 490 IPR007728

Functions

Description
EC Number
Subcellular Localization
  • Nucleus
  • Chromosome, centromere
  • Associates with centromeric constitutive heterochromatin
PANTHER Family
PANTHER Subfamily
PANTHER Protein Class
PANTHER Pathway Category No pathway information available

2 GO annotations of cellular component

Name Definition
chromosome, centromeric region The region of a chromosome that includes the centromeric DNA and associated proteins. In monocentric chromosomes, this region corresponds to a single area of the chromosome, whereas in holocentric chromosomes, it is evenly distributed along the chromosome.
nucleus A membrane-bounded organelle of eukaryotic cells in which chromosomes are housed and replicated. In most cells, the nucleus contains all of the cell's chromosomes except the organellar chromosomes, and is the site of RNA synthesis and processing. In some species, or in specialized cell types, RNA metabolism or DNA replication may be absent.

4 GO annotations of molecular function

Name Definition
double-stranded DNA binding Binding to double-stranded DNA.
histone methyltransferase activity Catalysis of the reaction: S-adenosyl-L-methionine + histone = S-adenosyl-L-homocysteine + methyl-histone. Histone methylation generally occurs on either an arginine or lysine residue.
histone-lysine N-methyltransferase activity Catalysis of the reaction: S-adenosyl-L-methionine + histone L-lysine = S-adenosyl-L-homocysteine + histone N6-methyl-L-lysine. The methylation of peptidyl-lysine in histones forms N6-methyl-L-lysine, N6,N6-dimethyl-L-lysine and N6,N6,N6-trimethyl-L-lysine derivatives.
zinc ion binding Binding to a zinc ion (Zn).

4 GO annotations of biological process

Name Definition
DNA-mediated transformation The direct uptake and incorporation of exogenous genetic material (DNA or RNA) into a cell from its surroundings through the cell envelope.
gene silencing by RNA-directed DNA methylation A small RNA-based gene silencing process in which small interfering RNAs (siRNAs) guide DNA methylation to the siRNA-generating genomic loci and other loci that are homologous to the siRNAs for de novo DNA methylation. This results in a heterochromatin assembly, a chromatin conformation that is refractory to transcription. In general this process consists of three phases: biogenesis of siRNAs, scaffold RNA production, and the formation of the guiding complex that recruits de novo DNA methyltransferases to the target loci. Transposable elements are silenced by this mechanism.
histone lysine methylation The modification of a histone by addition of one or more methyl groups to a lysine residue.
histone methylation The modification of histones by addition of methyl groups.

4 homologous proteins in AiPD

UniProt AC Gene Name Protein Name Species Evidence Code
Q0VD24 SETMAR Histone-lysine N-methyltransferase SETMAR Bos taurus (Bovine) PR
Q949T8 ASHR3 Histone-lysine N-methyltransferase ASHR3 Arabidopsis thaliana (Mouse-ear cress) PR
Q9C5P0 SUVH8 Histone-lysine N-methyltransferase, H3 lysine-9 specific SUVH8 Arabidopsis thaliana (Mouse-ear cress) PR
Q9LVU3 At5g47160 YDG domain-containing protein At5g47160 Arabidopsis thaliana (Mouse-ear cress) PR
10 20 30 40 50 60
MGSSHIPLDP SLNPSPSLIP KLEPVTESTQ NLAFQLPNTN PQALISSAVS DFNEATDFSS
70 80 90 100 110 120
DYNTVAESAR SAFAQRLQRH DDVAVLDSLT GAIVPVEENP EPEPNPYSTS DSSPSVATQR
130 140 150 160 170 180
PRPQPRSSEL VRITDVGPES ERQFREHVRK TRMIYDSLRM FLMMEEAKRN GVGGRRARAD
190 200 210 220 230 240
GKAGKAGSMM RDCMLWMNRD KRIVGSIPGV QVGDIFFFRF ELCVMGLHGH PQSGIDFLTG
250 260 270 280 290 300
SLSSNGEPIA TSVIVSGGYE DDDDQGDVIM YTGQGGQDRL GRQAEHQRLE GGNLAMERSM
310 320 330 340 350 360
YYGIEVRVIR GLKYENEVSS RVYVYDGLFR IVDSWFDVGK SGFGVFKYRL ERIEGQAEMG
370 380 390 400 410 420
SSVLKFARTL KTNPLSVRPR GYINFDISNG KENVPVYLFN DIDSDQEPLY YEYLAQTSFP
430 440 450 460 470 480
PGLFVQQSGN ASGCDCVNGC GSGCLCEAKN SGEIAYDYNG TLIRQKPLIH ECGSACQCPP
490 500 510 520 530 540
SCRNRVTQKG LRNRLEVFRS LETGWGVRSL DVLHAGAFIC EYAGVALTRE QANILTMNGD
550 560 570 580 590 600
TLVYPARFSS ARWEDWGDLS QVLADFERPS YPDIPPVDFA MDVSKMRNVA CYISHSTDPN
610 620 630 640
VIVQFVLHDH NSLMFPRVML FAAENIPPMT ELSLDYGVVD DWNAKLAICN